Financials
- Market Capitalization 375.85 B
- Employee 75 K
- Founded N/A
- CEO Robert M Davis
- Website www.merck.com
- Headquarter New Jersey, United States
- FIGI BBG000BPD168
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 17 | JNJ Johnson & Johnson Common Stock | 278.47 USD | +1.14% | +4.58% | +8.77% | +56.56% | 671.08 B USD | ||
| 23 | ABBV AbbVie Inc. Common Stock | 260.21 USD | -0.57% | +0.61% | +5.37% | +22.44% | 459.82 B USD | ||
| 43 | NVS Novartis AG | 163.07 USD | +0.39% | +5.53% | +5.08% | +25.62% | 311.16 B USD | ||
| 58 | AMGN Amgen Inc. - Common Stock | 444.12 USD | +0.29% | +1.42% | +12.90% | +58.73% | 240.11 B USD |
Frequently asked questions about Merck & Co., Inc.
What is the Merck & Co., Inc. stock price today?
The current price of Merck & Co., Inc. (MRK) is 152.34. Over the past 24 hours, the stock has changed by +0.41%. Follow the MRK chart for real-time price dynamics.
What is the stock ticker of Merck & Co., Inc.?
Merck & Co., Inc. trades under the ticker MRK. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Merck & Co., Inc. stock going up?
MRK has changed by +4.15% over the last week, +17.72% over the last month, and +81.81% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Merck & Co., Inc.?
Merck & Co., Inc. currently has a market capitalization of 375.85 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
Does Merck & Co., Inc. release financial reports?
Yes. You can track Merck & Co., Inc. financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What were Merck & Co., Inc. earnings last quarter?
Last quarter, Merck & Co., Inc. reported earnings of -0.54 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Merck & Co., Inc. revenue for the last quarter?
Merck & Co., Inc. reported quarterly revenue of 16.61 B. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Merck & Co., Inc. net income for the last quarter?
Merck & Co., Inc. reported net income of -1.33 B for the last quarter. The previous quarter showed -4.24 B, which means net income changed by +68.51%.
Does Merck & Co., Inc. pay dividends?
Merck & Co., Inc. paid a dividend per share of 0.85. The current dividend yield is 4.51%. Dividend data can help income-focused investors evaluate the stock.
Is Merck & Co., Inc. a good dividend stock?
Merck & Co., Inc. currently has a dividend yield of 4.51%. Previously, the dividend yield was 4.78%, compared with 3.12% a year earlier. When evaluating dividend stocks, investors should also consider earnings, cash flow, and the sustainability of future dividend payments.
How many employees does Merck & Co., Inc. have?
As of the latest available data, Merck & Co., Inc. has 75 K employees. Workforce size can provide additional context about the company's scale and operations.
What is Merck & Co., Inc. EBITDA?
Merck & Co., Inc. EBITDA is 999 M, and its EBITDA margin is 6.02%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Merck & Co., Inc. stock?
You can buy Merck & Co., Inc. (MRK) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Merck & Co., Inc. stock?
Investing in Merck & Co., Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MRK chart and related analysis on metatrader.com as part of your research.